| Literature DB >> 25435120 |
Carlos Rodriguez-Galindo1, Darren B Orbach2, Deborah VanderVeen3.
Abstract
Retinoblastoma is the most common neoplasm of the eye in childhood, and represents 3% of all childhood malignancies. Retinoblastoma is a cancer of the very young; two-thirds are diagnosed before 2 years of age and 95% before 5 years. Retinoblastoma presents in 2 distinct clinical forms: (1) a bilateral or multifocal, heritable form (25% of all cases), characterized by the presence of germline mutations of the RB1 gene; and (2) a unilateral or unifocal form (75% of all cases), 90% of which are nonhereditary. The treatment of retinoblastoma is multidisciplinary and is designed primarily to save life and preserve vision.Entities:
Keywords: Chemotherapy; Germline mutation; Retinoblastoma; Second malignant neoplasms
Mesh:
Year: 2015 PMID: 25435120 DOI: 10.1016/j.pcl.2014.09.014
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278